Baker Chad R Illumina, Inc. Transaction History

Baker Chad R

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 17, 2023	SELL	$128.91 - $192.44 $1.29 Million - $1.93 Million	-10,040 Reduced 43.93%	12,815 $1.76 Million
Q2 2023 Jul 18, 2023	BUY	$183.43 - $232.67 $160,501 - $203,586	875 Added 3.98%	22,855 $4.29 Million
Q1 2023 Apr 27, 2023	BUY	$193.75 - $232.55 $89,125 - $106,973	460 Added 2.14%	21,980 $5.11 Million
Q4 2022 Feb 10, 2023	SELL	$187.24 - $242.74 $47,746 - $61,898	-255 Reduced 1.17%	21,520 $4.35 Million
Q3 2022 Nov 03, 2022	SELL	$177.23 - $227.44 $8,861 - $11,372	-50 Reduced 0.23%	21,775 $4.16 Million
Q1 2020 May 01, 2020	BUY	$209.2 - $335.53 $779,270 - $1.25 Million	3,725 Added 20.58%	21,825 $5.96 Million
Q4 2019 Feb 12, 2020	BUY	$288.29 - $335.49 $663,067 - $771,627	2,300 Added 14.56%	18,100 $6.01 Million
Q1 2018 May 14, 2018	BUY	$209.54 - $253.91 $136,201 - $165,041	650 Added 4.29%	15,800 $3.74 Million
Q2 2017 Aug 14, 2017	BUY	N/A	15,150	15,150 $2.63 Million

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Baker Chad R, based on Form 13F filings with the SEC.

Stay updated on Baker Chad R with notifications on news.